Why fentanyl overdose and cannabis legalization can be a national security threat.

1623404181 maxresdefault



The US has a record number of deaths related to drug overdoses in 2020, particularly Fentanyl overdose. China is the biggest source of supplier of Fentanyl or Fentanyl ingredients. The ongoing cannabis legalization in the US can post a national security threat as the US becomes the largest cannabis consumption country and China the largest supplier of cannabis products. China has taken advantage of the US drug crisis; its cannabis industry will take advantage of American addictions and engage in new opium wars.

0:00 The Fentanyl crisis
3:20 The opium war
5:32 National security risks of marijuana legalization

******************
We discuss world economy, history, and politics. Our main focus is U.S.-China relations. We make short videos and tell you the hidden stories.
******************
References:
https://www.baltimoresun.com/opinion/columnists/dan-rodricks/bs-md-rodricks-0420-overdose-deaths-20210420-p3biwd3bpfeyxf6wdstggepcm4-story.html

https://hemptoday.net/the-chinese-strategy-planning-a-roadmap-to-hemps-future/

https://www.therecoveryvillage.com/drug-addiction/news/china-bans-fentanyl/

http://yy.mfbbl.com/a/xinwenzixun/100.html

https://www.yicai.com/news/100305338.html

https://www.brookings.edu/research/fentanyl-and-geopolitics-controlling-opioid-supply-from-china/

******************
🔔 Subscribe for updates: https://www.youtube.com/c/LeisRealTalk​​
******************
🔵 Make sure to share this video with your friends!
Follow us on our Website: https://leisrealtalk.com/​​​​​
Follow us on Twitter: https://twitter.com/LeisRealTalk​​​​​​​
Follow us on Facebook: https://www.facebook.com/leisrealtalk​​
******************
MORE VIDEOS:

Why Taiwan Semiconductor drives US Korea Japan China relations
https://www.youtube.com/watch?v=jWV5DCBd9Kg

What Chinese companies went public in the US stock market amid US China competition?
https://www.youtube.com/watch?v=ek0lh-8CGMU

Be amazed: the causes for the declining Chinese population and birth rates are hilarious but sad.
https://www.youtube.com/watch?v=9hFa4Bqa964

How brands battle Chinese copycats, knockoffs, and trademark squatters:
https://www.youtube.com/watch?v=kGvMEYFPSGI

Xi Jinping’s 4 fears
https://youtu.be/edVtp0xzkr4

Neocolonialism & Belt Road agenda disclosed by the Chinese professor: https://youtu.be/UjY8LDGlwxE

Chinese knockoffs explained: Why Chinese are copycats?
https://youtu.be/kwA6ACulqsw

H&M in trouble? In-depth look at the Chinese boycott of Nike, Adidas over xinjiang cotton.
https://youtu.be/A0SYoiPf4KM

Elon Musk’s rise and fall. Is Tesla in trouble in China? His Chinese made Tesla cars may cost him.
https://youtu.be/bQU3m9gHrXg

Doing business in China: Jack Ma’s trouble & Elon Musk’s bad news.
https://youtu.be/Up_rbq_DpeM

China losing young people? Chinese growing old? The loss of Chinese labor force will cost China.
https://youtu.be/J0NRmw84nVc

The China 5 year chip plan? The reality of Chinese chip industry and the China chip problem.
https://youtu.be/OK3XCob8D-s

US – China | The Secretive China Semiconductor Industry Strategies
https://youtu.be/-uLYytuazWk

******************
OUR PLAYLISTS:
Unseen Fortune Documentaries: https://youtube.com/playlist?list=PL98Y1OoA0uGty5g24gHM438Hwm97ongSh

Dealing with mainland China: https://youtube.com/playlist?list=PL98Y1OoA0uGuGF5pa3Qs6hqy41ITPoHou

China Uncovered: https://youtube.com/playlist?list=PL98Y1OoA0uGsSnmlW5zsR35–g9pMFfOJ

Current Affairs – U.S., China, and Beyond: https://youtube.com/playlist?list=PL98Y1OoA0uGvpHWeC95MjdXVmnjW5nBGu

Tech & Media: https://youtube.com/playlist?list=PL98Y1OoA0uGsRA6-o6uMN59Knb1LR72Mn
*****************
#cannabislegalization #Americanaddiction #nationalsecuritycrisis #marijuanalegalization #USChina #USdrugcrisis #fentanylcrisis #cannabisindustry #drugoverdose #cannabisrisks #Chinesedrugthreat #cannabisconsumption #Chinesethreat #fentanylChina #fentanyldeadly #opiumwars #cannabisproducts

source

Leave a Reply

Your email address will not be published. Required fields are marked *